These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12645649)

  • 1. Karyotypic abnormalities in myelofibrosis following polycythemia vera.
    Andrieux J; Demory JL; Caulier MT; Agape P; Wetterwald M; Bauters F; Laï JL
    Cancer Genet Cytogenet; 2003 Jan; 140(2):118-23. PubMed ID: 12645649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis.
    Miller JB; Testa JR; Lindgren V; Rowley JD
    Cancer; 1985 Feb; 55(3):582-91. PubMed ID: 3965109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].
    Roche-Lestienne C; Andrieux J
    Pathol Biol (Paris); 2007 Feb; 55(1):49-55. PubMed ID: 16901657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotype and molecular cytogenetic studies in polycythemia vera.
    Andrieux JL; Demory JL
    Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy 1q in polycythemia vera and its relation to disease transition.
    Swolin B; Weinfeld A; Westin J
    Am J Hematol; 1986 Jun; 22(2):155-67. PubMed ID: 3706291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage.
    Boiocchi L; Mathew S; Gianelli U; Iurlo A; Radice T; Barouk-Fox S; Knowles DM; Orazi A
    Mod Pathol; 2013 Dec; 26(12):1577-85. PubMed ID: 23787440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
    Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
    Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial trisomy of the long arm of chromosome 1 in myelofibrosis and polycythemia vera.
    Hsu LY; Pinchiaroli D; Gilbert HS; Wittman R; Hirschhorn K
    Am J Hematol; 1977; 2(4):375-83. PubMed ID: 602927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chromosomal profile of polycythemia vera.
    Rege-Cambrin G; Mecucci C; Tricot G; Michaux JL; Louwagie A; Van Hove W; Francart H; Van den Berghe H
    Cancer Genet Cytogenet; 1987 Apr; 25(2):233-45. PubMed ID: 3828970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial trisomy 1q in idiopathic myelofibrosis.
    Donti E; Tabilio A; Bocchini F; Falzetti F; Martelli MF; Grignani F; Donti GV
    Leuk Res; 1990; 14(11-12):1035-40. PubMed ID: 2280601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.
    Tang G; Hidalgo Lopez JE; Wang SA; Hu S; Ma J; Pierce S; Zuo W; Carballo-Zarate AA; Yin CC; Tang Z; Li S; Medeiros LJ; Verstovsek S; Bueso-Ramos CE
    Haematologica; 2017 Sep; 102(9):1511-1518. PubMed ID: 28473622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
    Mora B; Giorgino T; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Cavalloni C; Barraco D; Merli M; Pietra D; Casalone R; Barbui T; Rotunno G; Cazzola M; Vannucchi AM; Passamonti F
    Haematologica; 2018 Sep; 103(9):e392-e394. PubMed ID: 29622658
    [No Abstract]   [Full Text] [Related]  

  • 13. Karyotypic and ras gene mutational analysis in idiopathic myelofibrosis.
    Reilly JT; Wilson G; Barnett D; Watmore A; Potter A
    Br J Haematol; 1994 Nov; 88(3):575-81. PubMed ID: 7819070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of chromosome 13 in myelofibrosis.
    Borgström GH; Knuutila S; Ruutu T; Pakkala A; Lahtinen R; de la Chapelle A
    Scand J Haematol; 1984 Jul; 33(1):15-21. PubMed ID: 6463583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome studies in 104 patients with polycythemia vera.
    Diez-Martin JL; Graham DL; Petitt RM; Dewald GW
    Mayo Clin Proc; 1991 Mar; 66(3):287-99. PubMed ID: 2002687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
    Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
    Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera.
    Davidovitz Y; Lev D; Ballin A; Tsudik A; Meytes D
    Cancer Genet Cytogenet; 1998 Mar; 101(2):156-8. PubMed ID: 9494620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
    Tefferi A; Mesa RA; Schroeder G; Hanson CA; Li CY; Dewald GW
    Br J Haematol; 2001 Jun; 113(3):763-71. PubMed ID: 11380468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple chromosomal changes and karyotypic evolution in a patient with myelofibrosis.
    Trautmann U; Rubbert A; Gramatzki M; Henschke F; Gebhart E
    Cancer Genet Cytogenet; 1992 Jul; 61(1):6-10. PubMed ID: 1638481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic studies in five patients with myelofibrosis and myeloid metaplasia.
    Carbone P; Barbata G; Mirto S; Marcenò R; Leone S; Granata G
    Cancer Genet Cytogenet; 1984 Jul; 12(3):209-15. PubMed ID: 6722762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.